About
Looking for more information?
Contact our responsive and friendly client services team any time.
(03) 9028 2888
clients@freshequities.com
INVESTOR PRESENTATION - Biotron Limited
Biotron Limited
Health
Biotron Limited (BIT) is a biotechnology company engaged in research, development, and commercialisation of drugs targeting viral diseases with unmet medical need. The Company focuses on the progression of the clinical development of the drug, BIT225, an investigational, orally-administered, novel antiviral compound in development by Biotron for treatment of HCV and HIV infections.
Read moreMarket Cap
$56.15m
Price at Close
$0.08
4w avg. Volume
763.03k
4w avg. Turnover
$60.38k
Announcements
| announcement | t+2 movement | date |
|---|---|---|
| +1.19% | 19 Nov 2020 |
| +1.19% | 19 Nov 2020 |
| +1.19% | 29 Oct 2020 |
| +1.19% | 29 Oct 2020 |
| -1.04% | 14 Oct 2020 |
| -1.04% | 14 Oct 2020 |
| +2.22% | 08 Oct 2020 |
| -4.55% | 06 Sep 2020 |
| +15.79% | 03 Sep 2020 |
| +15.79% | 03 Sep 2020 |
Market Data
Current Price
$0.08
52WK HIGH
$0.185
52WK LOW
$0.058
1YR RETURN
+31.15%
1YR RETURN VS. SECTOR
-6.37%
90 DAY RETURN
-12.09%
ASX RANK
1,114
/2,047
SECTOR RANK
98
/168
SHARES OUTSTANDING
701.93m
Biotron Limited
Health
Biotron Limited (BIT) is a biotechnology company engaged in research, development, and commercialisation of drugs targeting viral diseases with unmet medical need. The Company focuses on the progression of the clinical development of the drug, BIT225, an investigational, orally-administered, novel antiviral compound in development by Biotron for treatment of HCV and HIV infections.
Read moreMarket Cap
$56.15m
Price at Close
$0.08
4w avg. Volume
763.03k
4w avg. Turnover
$60.38k
ASX:BIT is not raising right now
Want to invest?
Contact Us
(03) 9028 2888
clients@freshequities.com
Address
Level 7, 388 Bourke St
Melbourne VIC 3000
Australia